Xenogeneic Arterial Bypass Graft

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$73,360.00
Award Year:
1995
Program:
SBIR
Phase:
Phase I
Contract:
1 R43 HL53192-01,
Award Id:
29497
Agency Tracking Number:
29497
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
2211 New Market Parkway, Suite, Marietta, GA, 30067
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
Steven Goldstein
() -
Business Contact:
() -
Research Institute:
n/a
Abstract
Although the autogenous saphenous vein is the vessel typically utilized in arterial bypass procedurarise in which it is not possible to use this vein, demanding an alternative method. The investigatofeasibility study in canine subjects to determine whether an immunologically modified xenogeneic vesendothelium can serve as a replacement of the autogenous saphenous vein. The investigators intend tothe tissue modification technique, and seek to optimize endothelial cell seeding. The final object oassess in vivo the biocompatibility of the implant, as well as its overall effectiveness as a graft.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government